The alternate O ‐methylation of p ‐ t Bu‐calix6arene is a well‐known method leading to the C 3v ‐symmetrical 1,3,5‐tris‐ O ‐Me‐ p ‐ t Bu‐calix6arene, a key compound for the development of platforms for supramolecular studies and in particular for the access to receptors in host–guest chemistry. The alternate O ‐methylation of the parent de‐ tert ‐butylated calix6arene remained elusive, precluding the development of similar C 3v ‐symmetrical 1,3,5‐tris‐ O ‐methylated receptors with an open cavity devoid of bulky t Bu groups at the large rim. In this work, we developed an efficient method for the synthesis of 1,3,5‐tris‐ O ‐Me‐calix6arene. This platform was further selectively derivatized on the small and large rims, producing notably a tris‐imidazole calix6arene‐based ligand forming a biomimetic funnel complex upon coordinating Zn 2+ , with an open cavity suitable for the inclusion of a bulky dopamine derivative.
Lepeintre et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: